nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—ABCB1—Dactinomycin—muscle cancer	0.168	0.258	CbGbCtD
Methylprednisolone—ABCB1—Vincristine—muscle cancer	0.104	0.159	CbGbCtD
Methylprednisolone—ABCB1—Etoposide—muscle cancer	0.095	0.146	CbGbCtD
Methylprednisolone—ABCB1—Doxorubicin—muscle cancer	0.0648	0.0993	CbGbCtD
Methylprednisolone—ABCB1—Methotrexate—muscle cancer	0.0628	0.0962	CbGbCtD
Methylprednisolone—CYP3A4—Vincristine—muscle cancer	0.0621	0.0952	CbGbCtD
Methylprednisolone—CYP3A4—Etoposide—muscle cancer	0.0569	0.0873	CbGbCtD
Methylprednisolone—CYP3A4—Doxorubicin—muscle cancer	0.0388	0.0595	CbGbCtD
Methylprednisolone—Petechiae—Methotrexate—muscle cancer	0.00139	0.00399	CcSEcCtD
Methylprednisolone—Neuritis—Doxorubicin—muscle cancer	0.00132	0.00381	CcSEcCtD
Methylprednisolone—Cardiac arrest—Etoposide—muscle cancer	0.00131	0.00378	CcSEcCtD
Methylprednisolone—Acute coronary syndrome—Vincristine—muscle cancer	0.0013	0.00373	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Vincristine—muscle cancer	0.00129	0.00371	CcSEcCtD
Methylprednisolone—Myocardial infarction—Vincristine—muscle cancer	0.00129	0.00371	CcSEcCtD
Methylprednisolone—Fungal infection—Doxorubicin—muscle cancer	0.00128	0.00368	CcSEcCtD
Methylprednisolone—Sweating—Vincristine—muscle cancer	0.00126	0.00363	CcSEcCtD
Methylprednisolone—Necrosis—Doxorubicin—muscle cancer	0.00126	0.00362	CcSEcCtD
Methylprednisolone—Abscess—Doxorubicin—muscle cancer	0.00125	0.00359	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Etoposide—muscle cancer	0.00122	0.00351	CcSEcCtD
Methylprednisolone—Glycosuria—Doxorubicin—muscle cancer	0.00122	0.00351	CcSEcCtD
Methylprednisolone—Petechiae—Doxorubicin—muscle cancer	0.0012	0.00345	CcSEcCtD
Methylprednisolone—Inflammation—Methotrexate—muscle cancer	0.00118	0.00338	CcSEcCtD
Methylprednisolone—Bronchospasm—Etoposide—muscle cancer	0.00118	0.00338	CcSEcCtD
Methylprednisolone—Hallucination—Vincristine—muscle cancer	0.00117	0.00338	CcSEcCtD
Methylprednisolone—Vasculitis—Methotrexate—muscle cancer	0.00117	0.00336	CcSEcCtD
Methylprednisolone—Sweating increased—Etoposide—muscle cancer	0.00116	0.00335	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Vincristine—muscle cancer	0.00116	0.00334	CcSEcCtD
Methylprednisolone—Erythema—Dactinomycin—muscle cancer	0.00115	0.00331	CcSEcCtD
Methylprednisolone—Amenorrhoea—Doxorubicin—muscle cancer	0.00112	0.00323	CcSEcCtD
Methylprednisolone—Cardiac disorder—Vincristine—muscle cancer	0.0011	0.00315	CcSEcCtD
Methylprednisolone—Skin exfoliation—Methotrexate—muscle cancer	0.00109	0.00313	CcSEcCtD
Methylprednisolone—Arthropathy—Doxorubicin—muscle cancer	0.00109	0.00313	CcSEcCtD
Methylprednisolone—Angiopathy—Vincristine—muscle cancer	0.00107	0.00308	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Dactinomycin—muscle cancer	0.00107	0.00307	CcSEcCtD
Methylprednisolone—Infestation NOS—Etoposide—muscle cancer	0.00107	0.00307	CcSEcCtD
Methylprednisolone—Infestation—Etoposide—muscle cancer	0.00107	0.00307	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Vincristine—muscle cancer	0.00106	0.00306	CcSEcCtD
Methylprednisolone—Acute coronary syndrome—Etoposide—muscle cancer	0.00105	0.00302	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Etoposide—muscle cancer	0.00104	0.003	CcSEcCtD
Methylprednisolone—Myocardial infarction—Etoposide—muscle cancer	0.00104	0.003	CcSEcCtD
Methylprednisolone—Malaise—Dactinomycin—muscle cancer	0.00104	0.00298	CcSEcCtD
Methylprednisolone—Mental disorder—Vincristine—muscle cancer	0.00103	0.00298	CcSEcCtD
Methylprednisolone—Ecchymosis—Methotrexate—muscle cancer	0.00103	0.00297	CcSEcCtD
Methylprednisolone—Inflammation—Doxorubicin—muscle cancer	0.00102	0.00293	CcSEcCtD
Methylprednisolone—Pulmonary oedema—Methotrexate—muscle cancer	0.00102	0.00292	CcSEcCtD
Methylprednisolone—Hiccups—Doxorubicin—muscle cancer	0.000988	0.00284	CcSEcCtD
Methylprednisolone—Myalgia—Dactinomycin—muscle cancer	0.000979	0.00282	CcSEcCtD
Methylprednisolone—Discomfort—Dactinomycin—muscle cancer	0.000968	0.00278	CcSEcCtD
Methylprednisolone—Thrombophlebitis—Methotrexate—muscle cancer	0.000957	0.00275	CcSEcCtD
Methylprednisolone—Diabetes mellitus—Methotrexate—muscle cancer	0.000952	0.00274	CcSEcCtD
Methylprednisolone—Skin exfoliation—Doxorubicin—muscle cancer	0.000943	0.00271	CcSEcCtD
Methylprednisolone—Fluid retention—Doxorubicin—muscle cancer	0.000938	0.0027	CcSEcCtD
Methylprednisolone—Infection—Dactinomycin—muscle cancer	0.000933	0.00268	CcSEcCtD
Methylprednisolone—Neuropathy—Doxorubicin—muscle cancer	0.000927	0.00267	CcSEcCtD
Methylprednisolone—Vertigo—Vincristine—muscle cancer	0.000923	0.00266	CcSEcCtD
Methylprednisolone—Oesophagitis—Doxorubicin—muscle cancer	0.000903	0.0026	CcSEcCtD
Methylprednisolone—Eye disorder—Etoposide—muscle cancer	0.000894	0.00257	CcSEcCtD
Methylprednisolone—Ecchymosis—Doxorubicin—muscle cancer	0.000893	0.00257	CcSEcCtD
Methylprednisolone—Convulsion—Vincristine—muscle cancer	0.00089	0.00256	CcSEcCtD
Methylprednisolone—Cardiac disorder—Etoposide—muscle cancer	0.000888	0.00255	CcSEcCtD
Methylprednisolone—Hypertension—Vincristine—muscle cancer	0.000887	0.00255	CcSEcCtD
Methylprednisolone—Pulmonary oedema—Doxorubicin—muscle cancer	0.000879	0.00253	CcSEcCtD
Methylprednisolone—Myalgia—Vincristine—muscle cancer	0.000875	0.00252	CcSEcCtD
Methylprednisolone—Angiopathy—Etoposide—muscle cancer	0.000868	0.0025	CcSEcCtD
Methylprednisolone—Immune system disorder—Etoposide—muscle cancer	0.000864	0.00249	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Etoposide—muscle cancer	0.000862	0.00248	CcSEcCtD
Methylprednisolone—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000856	0.00246	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000855	0.00246	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Vincristine—muscle cancer	0.000839	0.00241	CcSEcCtD
Methylprednisolone—Infection—Vincristine—muscle cancer	0.000833	0.0024	CcSEcCtD
Methylprednisolone—Thrombophlebitis—Doxorubicin—muscle cancer	0.000828	0.00238	CcSEcCtD
Methylprednisolone—Osteoarthritis—Methotrexate—muscle cancer	0.000828	0.00238	CcSEcCtD
Methylprednisolone—Diabetes mellitus—Doxorubicin—muscle cancer	0.000824	0.00237	CcSEcCtD
Methylprednisolone—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	0.000824	0.00237	CcSEcCtD
Methylprednisolone—Nervous system disorder—Vincristine—muscle cancer	0.000823	0.00237	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Vincristine—muscle cancer	0.000811	0.00233	CcSEcCtD
Methylprednisolone—Fatigue—Dactinomycin—muscle cancer	0.000809	0.00233	CcSEcCtD
Methylprednisolone—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000791	0.00227	CcSEcCtD
Methylprednisolone—Irritability—Methotrexate—muscle cancer	0.00079	0.00227	CcSEcCtD
Methylprednisolone—Mood swings—Methotrexate—muscle cancer	0.000784	0.00226	CcSEcCtD
Methylprednisolone—Hypotension—Vincristine—muscle cancer	0.000784	0.00226	CcSEcCtD
Methylprednisolone—Feeling abnormal—Dactinomycin—muscle cancer	0.000774	0.00223	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Etoposide—muscle cancer	0.000772	0.00222	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000768	0.00221	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000764	0.0022	CcSEcCtD
Methylprednisolone—Increased appetite—Doxorubicin—muscle cancer	0.000763	0.0022	CcSEcCtD
Methylprednisolone—Insomnia—Vincristine—muscle cancer	0.000759	0.00218	CcSEcCtD
Methylprednisolone—Paraesthesia—Vincristine—muscle cancer	0.000753	0.00217	CcSEcCtD
Methylprednisolone—Malaise—Etoposide—muscle cancer	0.000751	0.00216	CcSEcCtD
Methylprednisolone—Breast disorder—Methotrexate—muscle cancer	0.000748	0.00215	CcSEcCtD
Methylprednisolone—Vertigo—Etoposide—muscle cancer	0.000748	0.00215	CcSEcCtD
Methylprednisolone—Abdominal pain—Dactinomycin—muscle cancer	0.000742	0.00214	CcSEcCtD
Methylprednisolone—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000741	0.00213	CcSEcCtD
Methylprednisolone—Cardiac failure—Doxorubicin—muscle cancer	0.000735	0.00211	CcSEcCtD
Methylprednisolone—Loss of consciousness—Etoposide—muscle cancer	0.000732	0.00211	CcSEcCtD
Methylprednisolone—Fatigue—Vincristine—muscle cancer	0.000723	0.00208	CcSEcCtD
Methylprednisolone—Convulsion—Etoposide—muscle cancer	0.000721	0.00208	CcSEcCtD
Methylprednisolone—Hypertension—Etoposide—muscle cancer	0.000719	0.00207	CcSEcCtD
Methylprednisolone—Osteoarthritis—Doxorubicin—muscle cancer	0.000717	0.00206	CcSEcCtD
Methylprednisolone—Affect lability—Doxorubicin—muscle cancer	0.000706	0.00203	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000704	0.00203	CcSEcCtD
Methylprednisolone—Pancreatitis—Methotrexate—muscle cancer	0.000702	0.00202	CcSEcCtD
Methylprednisolone—Discomfort—Etoposide—muscle cancer	0.0007	0.00201	CcSEcCtD
Methylprednisolone—Hypersensitivity—Dactinomycin—muscle cancer	0.000692	0.00199	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Vincristine—muscle cancer	0.000686	0.00197	CcSEcCtD
Methylprednisolone—Confusional state—Etoposide—muscle cancer	0.000685	0.00197	CcSEcCtD
Methylprednisolone—Cardiac arrest—Doxorubicin—muscle cancer	0.000682	0.00196	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Etoposide—muscle cancer	0.000679	0.00195	CcSEcCtD
Methylprednisolone—Mood swings—Doxorubicin—muscle cancer	0.000679	0.00195	CcSEcCtD
Methylprednisolone—Infection—Etoposide—muscle cancer	0.000675	0.00194	CcSEcCtD
Methylprednisolone—Asthenia—Dactinomycin—muscle cancer	0.000674	0.00194	CcSEcCtD
Methylprednisolone—Tachycardia—Etoposide—muscle cancer	0.000663	0.00191	CcSEcCtD
Methylprednisolone—Abdominal pain—Vincristine—muscle cancer	0.000663	0.00191	CcSEcCtD
Methylprednisolone—Skin disorder—Etoposide—muscle cancer	0.00066	0.0019	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Etoposide—muscle cancer	0.000657	0.00189	CcSEcCtD
Methylprednisolone—Breast disorder—Doxorubicin—muscle cancer	0.000648	0.00186	CcSEcCtD
Methylprednisolone—Diarrhoea—Dactinomycin—muscle cancer	0.000642	0.00185	CcSEcCtD
Methylprednisolone—Infestation NOS—Methotrexate—muscle cancer	0.000638	0.00184	CcSEcCtD
Methylprednisolone—Infestation—Methotrexate—muscle cancer	0.000638	0.00184	CcSEcCtD
Methylprednisolone—Hypotension—Etoposide—muscle cancer	0.000635	0.00183	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000632	0.00182	CcSEcCtD
Methylprednisolone—Muscular weakness—Doxorubicin—muscle cancer	0.000632	0.00182	CcSEcCtD
Methylprednisolone—Abdominal distension—Doxorubicin—muscle cancer	0.000624	0.0018	CcSEcCtD
Methylprednisolone—Hypersensitivity—Vincristine—muscle cancer	0.000618	0.00178	CcSEcCtD
Methylprednisolone—Sweating—Methotrexate—muscle cancer	0.000612	0.00176	CcSEcCtD
Methylprednisolone—Paraesthesia—Etoposide—muscle cancer	0.00061	0.00176	CcSEcCtD
Methylprednisolone—Pancreatitis—Doxorubicin—muscle cancer	0.000608	0.00175	CcSEcCtD
Methylprednisolone—Asthenia—Vincristine—muscle cancer	0.000602	0.00173	CcSEcCtD
Methylprednisolone—Vomiting—Dactinomycin—muscle cancer	0.000597	0.00172	CcSEcCtD
Methylprednisolone—Rash—Dactinomycin—muscle cancer	0.000592	0.0017	CcSEcCtD
Methylprednisolone—Fatigue—Etoposide—muscle cancer	0.000586	0.00169	CcSEcCtD
Methylprednisolone—Haemoglobin—Methotrexate—muscle cancer	0.000576	0.00166	CcSEcCtD
Methylprednisolone—Diarrhoea—Vincristine—muscle cancer	0.000574	0.00165	CcSEcCtD
Methylprednisolone—Haemorrhage—Methotrexate—muscle cancer	0.000573	0.00165	CcSEcCtD
Methylprednisolone—Weight increased—Doxorubicin—muscle cancer	0.000564	0.00162	CcSEcCtD
Methylprednisolone—Feeling abnormal—Etoposide—muscle cancer	0.00056	0.00161	CcSEcCtD
Methylprednisolone—Nausea—Dactinomycin—muscle cancer	0.000558	0.0016	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Etoposide—muscle cancer	0.000556	0.0016	CcSEcCtD
Methylprednisolone—Dizziness—Vincristine—muscle cancer	0.000555	0.0016	CcSEcCtD
Methylprednisolone—Infestation NOS—Doxorubicin—muscle cancer	0.000553	0.00159	CcSEcCtD
Methylprednisolone—Infestation—Doxorubicin—muscle cancer	0.000553	0.00159	CcSEcCtD
Methylprednisolone—Visual impairment—Methotrexate—muscle cancer	0.000552	0.00159	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000542	0.00156	CcSEcCtD
Methylprednisolone—Urticaria—Etoposide—muscle cancer	0.00054	0.00155	CcSEcCtD
Methylprednisolone—Abdominal pain—Etoposide—muscle cancer	0.000537	0.00155	CcSEcCtD
Methylprednisolone—Eye disorder—Methotrexate—muscle cancer	0.000535	0.00154	CcSEcCtD
Methylprednisolone—Vomiting—Vincristine—muscle cancer	0.000533	0.00153	CcSEcCtD
Methylprednisolone—Cardiac disorder—Methotrexate—muscle cancer	0.000532	0.00153	CcSEcCtD
Methylprednisolone—Sweating—Doxorubicin—muscle cancer	0.00053	0.00152	CcSEcCtD
Methylprednisolone—Rash—Vincristine—muscle cancer	0.000529	0.00152	CcSEcCtD
Methylprednisolone—Dermatitis—Vincristine—muscle cancer	0.000528	0.00152	CcSEcCtD
Methylprednisolone—Headache—Vincristine—muscle cancer	0.000525	0.00151	CcSEcCtD
Methylprednisolone—Angiopathy—Methotrexate—muscle cancer	0.00052	0.0015	CcSEcCtD
Methylprednisolone—Immune system disorder—Methotrexate—muscle cancer	0.000517	0.00149	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Methotrexate—muscle cancer	0.000516	0.00149	CcSEcCtD
Methylprednisolone—Bradycardia—Doxorubicin—muscle cancer	0.000505	0.00145	CcSEcCtD
Methylprednisolone—Mental disorder—Methotrexate—muscle cancer	0.000502	0.00144	CcSEcCtD
Methylprednisolone—Hypersensitivity—Etoposide—muscle cancer	0.000501	0.00144	CcSEcCtD
Methylprednisolone—Malnutrition—Methotrexate—muscle cancer	0.000499	0.00143	CcSEcCtD
Methylprednisolone—Erythema—Methotrexate—muscle cancer	0.000499	0.00143	CcSEcCtD
Methylprednisolone—Haemoglobin—Doxorubicin—muscle cancer	0.000499	0.00143	CcSEcCtD
Methylprednisolone—Nausea—Vincristine—muscle cancer	0.000498	0.00143	CcSEcCtD
Methylprednisolone—Rhinitis—Doxorubicin—muscle cancer	0.000497	0.00143	CcSEcCtD
Methylprednisolone—Haemorrhage—Doxorubicin—muscle cancer	0.000496	0.00143	CcSEcCtD
Methylprednisolone—Asthenia—Etoposide—muscle cancer	0.000488	0.0014	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Doxorubicin—muscle cancer	0.000487	0.0014	CcSEcCtD
Methylprednisolone—Pruritus—Etoposide—muscle cancer	0.000481	0.00138	CcSEcCtD
Methylprednisolone—Visual impairment—Doxorubicin—muscle cancer	0.000478	0.00138	CcSEcCtD
Methylprednisolone—Diarrhoea—Etoposide—muscle cancer	0.000465	0.00134	CcSEcCtD
Methylprednisolone—Eye disorder—Doxorubicin—muscle cancer	0.000464	0.00133	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Methotrexate—muscle cancer	0.000463	0.00133	CcSEcCtD
Methylprednisolone—Cardiac disorder—Doxorubicin—muscle cancer	0.00046	0.00132	CcSEcCtD
Methylprednisolone—Angiopathy—Doxorubicin—muscle cancer	0.00045	0.00129	CcSEcCtD
Methylprednisolone—Malaise—Methotrexate—muscle cancer	0.00045	0.00129	CcSEcCtD
Methylprednisolone—Dizziness—Etoposide—muscle cancer	0.000449	0.00129	CcSEcCtD
Methylprednisolone—Immune system disorder—Doxorubicin—muscle cancer	0.000448	0.00129	CcSEcCtD
Methylprednisolone—Vertigo—Methotrexate—muscle cancer	0.000448	0.00129	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Doxorubicin—muscle cancer	0.000447	0.00129	CcSEcCtD
Methylprednisolone—Arrhythmia—Doxorubicin—muscle cancer	0.000443	0.00127	CcSEcCtD
Methylprednisolone—Mental disorder—Doxorubicin—muscle cancer	0.000435	0.00125	CcSEcCtD
Methylprednisolone—Convulsion—Methotrexate—muscle cancer	0.000432	0.00124	CcSEcCtD
Methylprednisolone—Vomiting—Etoposide—muscle cancer	0.000432	0.00124	CcSEcCtD
Methylprednisolone—Malnutrition—Doxorubicin—muscle cancer	0.000432	0.00124	CcSEcCtD
Methylprednisolone—Erythema—Doxorubicin—muscle cancer	0.000432	0.00124	CcSEcCtD
Methylprednisolone—Rash—Etoposide—muscle cancer	0.000428	0.00123	CcSEcCtD
Methylprednisolone—Dermatitis—Etoposide—muscle cancer	0.000428	0.00123	CcSEcCtD
Methylprednisolone—Headache—Etoposide—muscle cancer	0.000426	0.00122	CcSEcCtD
Methylprednisolone—Myalgia—Methotrexate—muscle cancer	0.000425	0.00122	CcSEcCtD
Methylprednisolone—Arthralgia—Methotrexate—muscle cancer	0.000425	0.00122	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000422	0.00121	CcSEcCtD
Methylprednisolone—Discomfort—Methotrexate—muscle cancer	0.000419	0.00121	CcSEcCtD
Methylprednisolone—Confusional state—Methotrexate—muscle cancer	0.00041	0.00118	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Methotrexate—muscle cancer	0.000407	0.00117	CcSEcCtD
Methylprednisolone—Infection—Methotrexate—muscle cancer	0.000404	0.00116	CcSEcCtD
Methylprednisolone—Nausea—Etoposide—muscle cancer	0.000404	0.00116	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Doxorubicin—muscle cancer	0.000401	0.00115	CcSEcCtD
Methylprednisolone—Nervous system disorder—Methotrexate—muscle cancer	0.000399	0.00115	CcSEcCtD
Methylprednisolone—Skin disorder—Methotrexate—muscle cancer	0.000395	0.00114	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Methotrexate—muscle cancer	0.000393	0.00113	CcSEcCtD
Methylprednisolone—Malaise—Doxorubicin—muscle cancer	0.000389	0.00112	CcSEcCtD
Methylprednisolone—Vertigo—Doxorubicin—muscle cancer	0.000388	0.00112	CcSEcCtD
Methylprednisolone—Syncope—Doxorubicin—muscle cancer	0.000387	0.00111	CcSEcCtD
Methylprednisolone—Hypotension—Methotrexate—muscle cancer	0.00038	0.00109	CcSEcCtD
Methylprednisolone—Loss of consciousness—Doxorubicin—muscle cancer	0.00038	0.00109	CcSEcCtD
Methylprednisolone—Convulsion—Doxorubicin—muscle cancer	0.000374	0.00108	CcSEcCtD
Methylprednisolone—Hypertension—Doxorubicin—muscle cancer	0.000373	0.00107	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000371	0.00107	CcSEcCtD
Methylprednisolone—Insomnia—Methotrexate—muscle cancer	0.000368	0.00106	CcSEcCtD
Methylprednisolone—Arthralgia—Doxorubicin—muscle cancer	0.000368	0.00106	CcSEcCtD
Methylprednisolone—Myalgia—Doxorubicin—muscle cancer	0.000368	0.00106	CcSEcCtD
Methylprednisolone—Anxiety—Doxorubicin—muscle cancer	0.000366	0.00105	CcSEcCtD
Methylprednisolone—Paraesthesia—Methotrexate—muscle cancer	0.000365	0.00105	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000365	0.00105	CcSEcCtD
Methylprednisolone—Discomfort—Doxorubicin—muscle cancer	0.000363	0.00105	CcSEcCtD
Methylprednisolone—Dyspepsia—Methotrexate—muscle cancer	0.000358	0.00103	CcSEcCtD
Methylprednisolone—Confusional state—Doxorubicin—muscle cancer	0.000355	0.00102	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Doxorubicin—muscle cancer	0.000352	0.00101	CcSEcCtD
Methylprednisolone—Fatigue—Methotrexate—muscle cancer	0.000351	0.00101	CcSEcCtD
Methylprednisolone—Infection—Doxorubicin—muscle cancer	0.00035	0.00101	CcSEcCtD
Methylprednisolone—Shock—Doxorubicin—muscle cancer	0.000347	0.000998	CcSEcCtD
Methylprednisolone—Nervous system disorder—Doxorubicin—muscle cancer	0.000346	0.000994	CcSEcCtD
Methylprednisolone—Tachycardia—Doxorubicin—muscle cancer	0.000344	0.00099	CcSEcCtD
Methylprednisolone—Skin disorder—Doxorubicin—muscle cancer	0.000342	0.000985	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Doxorubicin—muscle cancer	0.000341	0.00098	CcSEcCtD
Methylprednisolone—Feeling abnormal—Methotrexate—muscle cancer	0.000335	0.000965	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Methotrexate—muscle cancer	0.000333	0.000958	CcSEcCtD
Methylprednisolone—Hypotension—Doxorubicin—muscle cancer	0.000329	0.000947	CcSEcCtD
Methylprednisolone—Urticaria—Methotrexate—muscle cancer	0.000323	0.00093	CcSEcCtD
Methylprednisolone—Abdominal pain—Methotrexate—muscle cancer	0.000322	0.000926	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000321	0.000924	CcSEcCtD
Methylprednisolone—Insomnia—Doxorubicin—muscle cancer	0.000319	0.000917	CcSEcCtD
Methylprednisolone—Paraesthesia—Doxorubicin—muscle cancer	0.000316	0.00091	CcSEcCtD
Methylprednisolone—Dyspepsia—Doxorubicin—muscle cancer	0.00031	0.000893	CcSEcCtD
Methylprednisolone—Fatigue—Doxorubicin—muscle cancer	0.000304	0.000874	CcSEcCtD
Methylprednisolone—Hypersensitivity—Methotrexate—muscle cancer	0.0003	0.000863	CcSEcCtD
Methylprednisolone—Asthenia—Methotrexate—muscle cancer	0.000292	0.00084	CcSEcCtD
Methylprednisolone—Feeling abnormal—Doxorubicin—muscle cancer	0.00029	0.000836	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000288	0.000829	CcSEcCtD
Methylprednisolone—Pruritus—Methotrexate—muscle cancer	0.000288	0.000828	CcSEcCtD
Methylprednisolone—Urticaria—Doxorubicin—muscle cancer	0.00028	0.000806	CcSEcCtD
Methylprednisolone—Abdominal pain—Doxorubicin—muscle cancer	0.000279	0.000802	CcSEcCtD
Methylprednisolone—Diarrhoea—Methotrexate—muscle cancer	0.000278	0.000801	CcSEcCtD
Methylprednisolone—Dizziness—Methotrexate—muscle cancer	0.000269	0.000774	CcSEcCtD
Methylprednisolone—Hypersensitivity—Doxorubicin—muscle cancer	0.00026	0.000747	CcSEcCtD
Methylprednisolone—Vomiting—Methotrexate—muscle cancer	0.000259	0.000745	CcSEcCtD
Methylprednisolone—Rash—Methotrexate—muscle cancer	0.000257	0.000738	CcSEcCtD
Methylprednisolone—Dermatitis—Methotrexate—muscle cancer	0.000256	0.000738	CcSEcCtD
Methylprednisolone—Headache—Methotrexate—muscle cancer	0.000255	0.000734	CcSEcCtD
Methylprednisolone—Asthenia—Doxorubicin—muscle cancer	0.000253	0.000727	CcSEcCtD
Methylprednisolone—Pruritus—Doxorubicin—muscle cancer	0.000249	0.000717	CcSEcCtD
Methylprednisolone—Nausea—Methotrexate—muscle cancer	0.000242	0.000696	CcSEcCtD
Methylprednisolone—Diarrhoea—Doxorubicin—muscle cancer	0.000241	0.000694	CcSEcCtD
Methylprednisolone—Dizziness—Doxorubicin—muscle cancer	0.000233	0.000671	CcSEcCtD
Methylprednisolone—Vomiting—Doxorubicin—muscle cancer	0.000224	0.000645	CcSEcCtD
Methylprednisolone—Rash—Doxorubicin—muscle cancer	0.000222	0.000639	CcSEcCtD
Methylprednisolone—Dermatitis—Doxorubicin—muscle cancer	0.000222	0.000639	CcSEcCtD
Methylprednisolone—Headache—Doxorubicin—muscle cancer	0.000221	0.000635	CcSEcCtD
Methylprednisolone—Nausea—Doxorubicin—muscle cancer	0.000209	0.000602	CcSEcCtD
